Yesterday (June 26), the Ministry of Commerce released the "2017 Chinese herbal medicine circulation market analysis report". This is the fifth consecutive year that the Ministry of Commerce has issued an analysis report on the circulation market of Chinese medicinal materials. It analyzes the domestic market and import and export trade of Chinese medicinal materials in 2017, and looks forward to the development trend of the circulation of Chinese medicinal materials.

▍ The price of traditional Chinese medicine has declined slightly

The report shows that the circulation market price of traditional Chinese medicine remained stable in 2017, with a slight decline.

Specifically, among the 741 common varieties of Chinese medicinal materials in the circulation market of Chinese medicinal materials in my country, the prices of 220 varieties have risen, the prices of 334 varieties have remained flat, and the prices of 187 varieties have fallen.

Compared with 2016, the number of varieties with price increases decreased by 7% in 2017, the number of varieties with price increases decreased by 12%, the total number of varieties with price increases and prices decreased by 10%, and the number of varieties with price decreases increased by 48%.

Top 20 Varieties of Price Increase in 2017:

The top 20 varieties of price decline in 2017 are as follows:

Professionals told the author that most of the varieties with rising or falling prices are small varieties with too narrow a range of drugs. The market price of these varieties, often the ups and downs are very obvious. Moreover, its market demand is not large, once the output comes up, it is easy to fall in price, and it is not easy for the price to rebound.

In the above table, the price of indigent, which rose in 2017, in fact, this variety, which was originally only more than ten yuan, has lost a few yuan so far this year, and the price has dropped sharply. The price of ebony, which also rose sharply in 2017, has now dropped several dollars.

The professional believes that some cold back odd medicinal varieties, and can not represent the overall trend of the industry. The overall situation of the Chinese herbal medicine industry still needs to be viewed comprehensively in terms of bulk varieties.

As for the research and judgment on the circulation development trend of traditional Chinese medicine, the report also mentioned that the trend of traditional Chinese medicine in 2018 is expected to be similar to that in 2015, with overall shock adjustment. Among them, the price of large varieties of home species is difficult to be optimistic, while the price of small varieties, wild varieties and animal varieties is expected to rise.

▍ Pharmaceutical enterprises to accelerate the layout of the origin

The importance of Chinese medicinal materials for Chinese herbal pieces and Chinese patent medicines is self-evident. It is not only the source of quality control, but also the key factor affecting the price.

In the past two years, the quality and resource control of Chinese herbal medicines have been the focus of attention and hot discussion in the industry. Therefore, raw materials have become the focus of many pharmaceutical companies in the layout of the industrial chain.

According to the report, in accordance with the requirements of "extending the industrial chain to the producing areas of traditional Chinese medicine" in the "Plan for the Protection and Development of traditional Chinese Medicine", listed companies such as Chinese traditional medicine, Kangmei, Tianshili, Tiandi Network, Zhenbao Island, Jiuzhoutong, Xiangxue and other listed companies have sunk their producing areas in various forms, and the competition for producing area resources is becoming increasingly fierce.

It is understood that at present, many traditional Chinese medicine enterprises, such as Kangmei and Xiangxue, have their own bases of traditional Chinese medicine.

According to public information, Kangmei has made acquisitions in Guangdong, Beijing, Sichuan, Anhui, Shanghai and other places, and is expected to continue to increase its national layout in the future, build its own production bases or acquire local large-scale production enterprises, so as to further enhance its market share.

▍ Large growth in drug and food homologous varieties

The report shows that in 2017, the development momentum of homologous varieties of medicine and food was strong, and the total demand growth rate of related varieties was 9.5, which was much higher than that of non-medicine and food homologous varieties.

With the continuous strengthening of the supervision of traditional Chinese medicine decoction pieces, more and more enterprises begin to transform the layout of medicine and food homologous products, and use some tonic medicinal materials for food and health food, so as to stimulate the increasing sales of such medicinal materials.

According to the 2017 Health consumption report released by Ali Health, people under the age of 40 have become the main force of health consumption, accounting for 72% of the consumer population. At the same time, the enhancement of health care awareness also directly stimulated the consumption of medicine and food homologous products.

Statistics from Tiandi Network, a traditional Chinese medicine, show that ginseng, Panax notoginseng, wolfberry fruit, scented tea and other homologous varieties of medicine and food have maintained a sales growth rate of more than 8% in the past two years.

With the concept of "medicine and food homology" being understood by more and more people, many pharmaceutical companies have also begun to actively layout the medicine and food homology industry, such as monkey mushroom biscuits, donkey-hide gelatin health tea, etc., the medicine and food homology industry has great potential.

Under the dual identity of medicine and food homology, the market demand will be further expanded. In this case, coupled with the current rising prices of medicinal materials, the prices of related Chinese medicinal materials may continue to rise, singing all the way.

Health Planning Commission announced the list of traditional Chinese medicine with the same source of medicine and food:

Clove, star anise, anise, sword bean, fennel, small thistle, yam, hawthorn, purslane, zaocys, black plum, papaya, hemp seed, daidaihua, Polygonatum odoratum, licorice, Angelica dahurica, white lentil, white lentil flower, longan meat (longan), cassia seed, nutmeg, cinnamis cinnamis, chamus, chamus, chamus, ageri, ageri, ageri, chambr, black jujube, sour jujube), Momordica grosvenori, curly lilies, honeysuckle, green fruit, houttuynia cordata, ginger (ginger, dried ginger), citrus dulcis, medlar, gardenia, amomum, stevia sea, poria cocos, citrus, peach kernel, mulberry, platycodon grandiflorum, lotus leaf, red seed, mustard seed, black seed, yellow bean root, yellow bean root, yellow bean root, yellow seed, glaucber, yellow seed, sophora japonica, Sophora japonica, Dandelion, Honey, Torreya, Semen Ziziphi Spinosae, Fresh Rhizome, Fresh Rhizome, Agkistrodon, Orange Peel, Mint, Coix Seed, Allium macrostemon, Raspberry, Agastache.

Attached: Price Changes of Key Varieties of Traditional Chinese Medicine in 2017